localized prostate cancer
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
localized prostate cancer
Oct 18, 2024, 12:22 |
Insight
Gustavo Viani: PACE-B supports SBRT as a noninferior option for prostate cancer
Gustavo Viani posted the following on LinkedIn: “PACE-B supports SBRT as a noninferior option for…
May 23, 2024, 01:11 |
Insight
Baris Turkbey: Over the years, we've developed organ segmentation and lesion detection models on localized prostate cancer
Baris Turkbey, Senior Clinician, and Radiologist at Molecular Imaging Branch, NCI, NIH, recently shared a…
May 20, 2024, 15:10 |
Insight
Sabine D. Brookman-May: A roadmap for future endpoint development
Sabine D. Brookman-May, Professor of Urology at Munchen University, shared on X/Twitter: "Very happy to share…
Apr 27, 2024, 10:00 |
Blog
Yüksel Ürün: How do experts agree on treating high-risk localized prostate cancer with clear evidence of T3 disease on MRI?
Yüksel Ürün, Doctorate Professor at the Faculty of Medicine, Ankara University, Turkey, shared on X/Twitter:…
All:
4
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube